Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 10 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

10 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
July 2, 2024 TPST P 4,672 $2.13 $9,951 9,573 Direct +95.33% Acquired -97.1% (price as of 2026-10-05)
Jan. 6, 2022 TPST P 1,700 $4.80 $8,160 1,901 Direct +845.77% Acquired -98.7% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 2, 2025 TPST Employee Stock Option (right to buy) Common Stock (270,000) $0.86 Jan. 1, 2035 270,000 Acquired
Jan. 3, 2024 TPST Employee Stock Option (right to buy) Common Stock (100,000) $4.66 Jan. 2, 2034 100,000 Acquired
Oct. 11, 2023 TPST Employee Stock Option (right to buy) Common Stock (325,000) $9.77 Oct. 10, 2033 325,000 Acquired
Jan. 3, 2023 TPST Employee Stock Option (right to buy) Common Stock (69,700) $1.23 Jan. 2, 2033 69,700 Acquired
June 21, 2022 TPST Stock Option (Right to Buy) Common Stock (55,680) $2.35 June 20, 2032 55,680 Acquired
Jan. 4, 2022 TPST Stock Option (Right to Buy) Common Stock (29,000) $5.45 Jan. 3, 2032 29,000 Acquired
June 25, 2021 TPST Stock Option (Right to Buy) Common Stock (61,945) $5.90 Nov. 15, 2030 61,945 Acquired
June 25, 2021 TPST Stock Option (Right to Buy) Common Stock (3,018) $10.25 March 9, 2031 3,018 Acquired
June 25, 2021 TPST Stock Option (Right to Buy) Common Stock (540,231) $26.40 April 28, 2031 540,231 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

TPST

Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2024 $481,749 · · $391,200 $175,838 · $13,800 $1,062,587
2023 $454,480 · · · $199,971 · $13,200 $3,384,949
2022 $437,000 · · · $142,025 · $12,200 $833,398

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.